Quel est le prix pour Neovacs S.A. (ALNEV)

Le prix pour Neovacs S.A. (ALNEV) est $0.00047446

Quelle est la capitalisation boursière pour Neovacs S.A. (ALNEV)

La capitalisation boursière pour Neovacs S.A. (ALNEV) est $82.80

Neovacs S.A. (ALNEV) Dividendes

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.

Année	Dividende (ajusté pour divisions d’actions)	Changez
Pas assez de données pour les dates fournies.

Année

Dividende (ajusté pour divisions d’actions)

Changez

Pas assez de données pour les dates fournies.

Année	Dividende	Changez
Pas assez de données pour les dates fournies.

Année

Dividende

Changez

Pas assez de données pour les dates fournies.

Entreprise	Nombre de paiements de dividendes	Pays
Novo Nordisk A/S NVO.US	52.00%	DK
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Regeneron Pharmaceuticals, Inc. REGN.US	5.00%	US
UCB SA UCB.BR	29.00%	BE
Argenx SE ARGX.US	0.00%	NL

Entreprise

Nombre de paiements de dividendes

Pays